Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Latest news

Oxford researchers develop wearable ultrasound patch for continuous pregnancy monitoring

New technology could help identify fetal complications earlier in high-risk pregnancies. Researchers at the University of Oxford and collaborators have helped develop a wearable ultrasound patch capable of continuously monitoring fetal wellbeing during pregnancy, offering a potential new approach to identifying complications earlier in high-risk pregnancies.

Targeted Removal of sFlt-1 in Very Preterm Preeclampsia: A Promising First-in-Human Pilot Study

A first-in-human pilot study, published in Nature Medicine, suggests that selectively removing a placenta-derived protein called soluble Fms-like tyrosine kinase 1 (sFlt-1) from the blood may be a safe and feasible way to help manage very preterm preeclampsia.

Oxford to lead Europe's largest miscarriage research centre in partnership with Tommy's

The Nuffield Department of Women's & Reproductive Health is proud to announce that it is now leading Tommy's National Centre for Miscarriage Research, alongside existing partners: the University of Birmingham, the University of Warwick, and Imperial College London.

Ovarian Cancer Awareness Day 2026 highlights the need for earlier detection and better outcomes

Today, on World Ovarian Cancer Day, we recognise the impact ovarian cancer has on women and families worldwide, and the urgent need for earlier diagnosis, improved treatment, and better survival outcomes. The day also highlights the importance of continued research to improve understanding of ovarian cancer biology, diagnosis, treatment, and patient outcomes. High-grade serous ovarian cancer is the most common subtype of ovarian cancer, with many patients diagnosed at an advanced stage. Survival outcomes remain closely linked to the stage at which the disease is diagnosed.

Publications

Post-catalysis structures of mitochondrial complex I with ubiquinol-10 bound in the active site

Journal article

Chung I. et al, (2026), Nature Communications, 17

Development of the INDIGO partnership knowledge exchange strategy

Journal article

Taylor Salisbury T. et al, (2026), SSM - Mental Health, 9, 100602 - 100602